ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

Schmidt Approve NCAB Authorizations

February 18, 1977

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999